MarketInOut Stock Screener Log In | Sign Up

J-Pharma Co Ltd

TSE • Healthcare • Biotechnology • Quote as of 10/30/2026
J-Pharma Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization7,319.75 mln
Float8.47 mln

Piotroski F-Score

4 / 9
Borderline

Relative Strength

69 / 100
Outperforming

ROE

-45.53
Deeply negative

ROA

-40.40
Deeply negative

Business Description

Founded in Yokohama, Japan in 2005, J-Pharma is a drug discovery company built around a specific class of proteins called amino acid transporters, particularly one known as LAT1. The company is advancing several drug candidates toward clinical trials, including a treatment for multiple sclerosis and related conditions affecting the nervous system. To support its research, J-Pharma works alongside universities and other research partners while also conducting its own detailed analysis of how these target proteins function and behave.

Key Fundamentals

EPS-85.12
ROE-45.53
ROIC-537
ROA-40.40
EBITDA, mln-1,598
EV / EBITDA-2.21
EV / EBIT-2.21

Quote Details

Last 403.00
Change -16 (-3.82%)
Open 413.00
Volume 84,400
Turnover 34,013,200
Average Volume 267,876

Financial Ratios

Current Ratio12.12
Price / Book1.90
Price / Tangible Book1.90

Financial Strength

Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.98% 43 / 100   
1 Month 0.25% 74 / 100   
2 Months 35.23% 96 / 100   
6 Months -33.83% 5 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog